Clinical trials & CROs sits within Healthcare & Medicine, the sector with the most direct life-or-death impact of any on this list — a category with a real, cited scale: 10.06% of global GDP in health expenditure, 2023 (World Bank / WHO Global Health Expenditure Database). Clinical trials & CROs is one of 16 of the category's 20 items directly backed by WHO's Global Health Observatory, essential-medicines lists, and other institutional health-data trackers, rather than an editorial judgment call.
In this category
Clinical trials & CROs is 1 of 20 items in Healthcare & Medicine. See the full ranked list, or browse all 20 Human Endeavors categories.